Middle-market private equity firm Ancor Capital Partners purchased STATinMED Research, a medical technology company that provides health economics and outcomes research to pharmaceutical, biotechnology and health information companies.
The Sept. 7 deal marks the Dallas-based firm's largest acquisition to date, according to a news release.
Terms of the transaction were not disclosed.
Vic Keller, Ancor Capital's managing director, will become chairman of STATinMED Research effective immediately.
Capital Southwest Corp., CION Investment Management LLC, Harbert Management Corp. and Dos Rios Partners served as Ancor Capital's partners to capitalize the acquisition with senior debt and co-invested equity.